These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20629124)

  • 1. Cognitive and functional decline in Huntington's disease: dementia criteria revisited.
    Peavy GM; Jacobson MW; Goldstein JL; Hamilton JM; Kane A; Gamst AC; Lessig SL; Lee JC; Corey-Bloom J
    Mov Disord; 2010 Jul; 25(9):1163-9. PubMed ID: 20629124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.
    Julayanont P; McFarland NR; Heilman KM
    J Neurol Sci; 2020 Jan; 408():116523. PubMed ID: 31678902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of depression on working memory in presymptomatic Huntington's disease.
    Nehl C; Ready RE; Hamilton J; Paulsen JS
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):342-6. PubMed ID: 11514640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Theory of mind" is impaired in Huntington's disease.
    Brüne M; Blank K; Witthaus H; Saft C
    Mov Disord; 2011 Mar; 26(4):671-8. PubMed ID: 21384426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the functional impact of cognitive impairment in Huntington's disease.
    Horta-Barba A; Martínez-Horta S; Pérez-Pérez J; Sampedro F; Puig-Davi A; Pagonabarraga J; Kulisevsky J
    J Neurol; 2022 Jul; 269(7):3541-3549. PubMed ID: 35061089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for specific cognitive deficits in preclinical Huntington's disease.
    Lawrence AD; Hodges JR; Rosser AE; Kershaw A; ffrench-Constant C; Rubinsztein DC; Robbins TW; Sahakian BJ
    Brain; 1998 Jul; 121 ( Pt 7)():1329-41. PubMed ID: 9679784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
    Robins Wahlin TB; Lundin A; Dear K
    Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
    Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
    J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
    Martinez-Horta S; Horta-Barba A; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Garcia-Ruiz P; Júlio F; Januário C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Neurol; 2020 May; 267(5):1527-1535. PubMed ID: 32030521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural abnormalities contribute to functional decline in Huntington's disease.
    Hamilton JM; Salmon DP; Corey-Bloom J; Gamst A; Paulsen JS; Jerkins S; Jacobson MW; Peavy G
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):120-2. PubMed ID: 12486282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.
    Jacobs M; Hart EP; van Zwet EW; Bentivoglio AR; Burgunder JM; Craufurd D; Reilmann R; Saft C; Roos RA;
    J Neurol; 2016 Oct; 263(10):2080-5. PubMed ID: 27435968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.
    Begeti F; Tan AY; Cummins GA; Collins LM; Guzman NV; Mason SL; Barker RA
    J Neurol; 2013 Nov; 260(11):2777-85. PubMed ID: 23922130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive assessment of asymptomatic Huntington's disease carriers].
    Gómez-Tortosa E; del Barrio Alba A; Sánchez Pernaute R; Benítez J; Barroso A; García Yébenes J
    Neurologia; 1997; 12(6):226-31. PubMed ID: 9303588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.